OSM and cancer: Myokines, such as IL-6, irisin/FNDC5, decorin, oncostatin M (OSM), and secreted protein acidic and rich in cysteine (SPARC), have shown the potential of a direct tumor-suppressive effect in different cancer cell lines, including PCa (13).